Cargando…
Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus specie...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318612/ https://www.ncbi.nlm.nih.gov/pubmed/35887412 http://dx.doi.org/10.3390/jof8070656 |
_version_ | 1784755336124563456 |
---|---|
author | Khambati, Alisha Wright, Robert Emery Das, Susmita Pasula, Shirisha Sepulveda, Alejandro Hernandez, Francis Kanwar, Mamta Chandrasekar, Pranatharthi Kumar, Ashok |
author_facet | Khambati, Alisha Wright, Robert Emery Das, Susmita Pasula, Shirisha Sepulveda, Alejandro Hernandez, Francis Kanwar, Mamta Chandrasekar, Pranatharthi Kumar, Ashok |
author_sort | Khambati, Alisha |
collection | PubMed |
description | Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus species, Aspergillus fumigatus, continues to be more prevalent in fungal endophthalmitis patients. However, due to overlapping clinical symptoms with other endophthalmitis etiology, fungal endophthalmitis pose a challenge in its diagnosis and treatment. Hence, it is critical to understand its pathobiology to develop and deploy proper therapeutic interventions for combating Aspergillus infections. This review highlights the different modes of Aspergillus transmission and the host immune response during endophthalmitis. Additionally, we discuss recent advancements in the diagnosis of fungal endophthalmitis. Finally, we comprehensively summarize various antifungal regimens and surgical options for the treatment of Aspergillus endophthalmitis. |
format | Online Article Text |
id | pubmed-9318612 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93186122022-07-27 Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments Khambati, Alisha Wright, Robert Emery Das, Susmita Pasula, Shirisha Sepulveda, Alejandro Hernandez, Francis Kanwar, Mamta Chandrasekar, Pranatharthi Kumar, Ashok J Fungi (Basel) Review Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus species, Aspergillus fumigatus, continues to be more prevalent in fungal endophthalmitis patients. However, due to overlapping clinical symptoms with other endophthalmitis etiology, fungal endophthalmitis pose a challenge in its diagnosis and treatment. Hence, it is critical to understand its pathobiology to develop and deploy proper therapeutic interventions for combating Aspergillus infections. This review highlights the different modes of Aspergillus transmission and the host immune response during endophthalmitis. Additionally, we discuss recent advancements in the diagnosis of fungal endophthalmitis. Finally, we comprehensively summarize various antifungal regimens and surgical options for the treatment of Aspergillus endophthalmitis. MDPI 2022-06-22 /pmc/articles/PMC9318612/ /pubmed/35887412 http://dx.doi.org/10.3390/jof8070656 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Khambati, Alisha Wright, Robert Emery Das, Susmita Pasula, Shirisha Sepulveda, Alejandro Hernandez, Francis Kanwar, Mamta Chandrasekar, Pranatharthi Kumar, Ashok Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments |
title | Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments |
title_full | Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments |
title_fullStr | Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments |
title_full_unstemmed | Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments |
title_short | Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments |
title_sort | aspergillus endophthalmitis: epidemiology, pathobiology, and current treatments |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318612/ https://www.ncbi.nlm.nih.gov/pubmed/35887412 http://dx.doi.org/10.3390/jof8070656 |
work_keys_str_mv | AT khambatialisha aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT wrightrobertemery aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT dassusmita aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT pasulashirisha aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT sepulvedaalejandro aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT hernandezfrancis aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT kanwarmamta aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT chandrasekarpranatharthi aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments AT kumarashok aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments |